Ligand-independent activation of steroid hormone receptors

Journal of Molecular Medicine

Volumn 76, Issue 7, 1998, Pages 469-479

  Weigel, Nancy L ^a,b   Zhang, Yixian ^a,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Androgen receptor; Estrogen receptor; Ligand independent; Phosphorylation; Progesterone receptor

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR; GLUCOCORTICOID RECEPTOR; LIGAND; PHOSPHATASE; PHOSPHOTRANSFERASE; PROGESTERONE RECEPTOR; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; STEROID HORMONE; STEROID RECEPTOR; VITAMIN D RECEPTOR;

ANIMAL CELL; CELL TYPE; CONTROLLED STUDY; ENZYME ACTIVITY; HORMONAL REGULATION; HORMONE RESPONSIVE ELEMENT; HUMAN; MONKEY; NONHUMAN; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; LIGANDS; RECEPTORS, STEROID; SIGNAL TRANSDUCTION; STEROIDS;

EID: 0031840580     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050241     Document Type: Review

References (85)

1. Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science 240:889-895
2. O'Malley BW, Conneely OM (1992) Minireview: orphan receptors: in search of a unifying hypothesis for activation. Mol Endocrinol 6:1359-1361
3. Fawell SE, Lees JA, White R, Parker MG (1990) Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell 60:953-962
4. Tsai M-J, O'Malley BW, Tsai M-J, O'Malley BW (eds) (1994) MBIU: mechanism of steroid hormone regulation of gene transcription. Landes, Austin
5. Sartorius CA, Melville MY, Hovland AR, Tung L, Takimoto GS, Horwitz KB (1994) A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform. Mol Endocrinol 8:1347-1360
6. Smith DF, Toft DO (1993) Steroid receptors and their associated proteins. Mol Endocrinol 7:4-11
7. Smith DF (1993) Dynamics of heat shock protein 90-progesterone receptor binding and the disactivation loop model for steroid receptor complexes. Mol Endocrinol 7:1418-1429
8. Beato M, Chalepakis G, Schauer M, Slater EP (1989) General review. DNA regulatory elements for steroid hormones. J Steroid Biochem 32:737-740
9. Ing NH, Beekman JM, Tsai SY, Tsai M-J, O'Malley BW (1992) Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II). J Biol Chem 267:17617-17623
10. Onate SA, Tsai SY, Tsai M-J, O'Malley BW (1995) Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357
11. Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM (1990) Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345:224-229
12. Leid M, Kastner P, Lyons R, Nakshatri H, Saunders M, Zacharewski T, Chen JY, Staub A, Gamier JM, Chambon P (1992) Purification, cloning and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68:377-397
13. Yu VC, Delsert C, Andersen B, Holloway JM, Devary OV, Naar AM, Kim SY, Boulin JM, Glass CK, Rosenfeld MG (1992) RXRb: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67:1251-1266
14. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK, Rosenfeld MG (1995) Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor corepressor. Nature 377:397-404
15. Kurokawa R, Soderstrom M, Horlein A, Halachmi S, Brown M, Rosenfeld MG, Glass CK (1995) Polarity-specific activities of retinoic acid receptors determined hy a co-repressor. Nature 377:451-454
16. Weigel NL (1996) Steroid hormone receptors and their regulation by phosphorylation. Biochem J 319:657-667
17. Denner LA, Weigel NL, Maxwell BL, Schrader WT, O'Malley BW (1990) Regulation of progesterone receptor-mediated transcription by phosphorylation. Science 250:1740-1743
18. Power RF, Lydon JP, Conneely OM, O'Malley BW (1991) Dopamine activation of an orphan member of the steroid receptor superfamily. Science 252:1546-1548
19. Power RF, Mani SK, Codina J, Conneely OM, O'Malley BW (1991) Dopaminergic and ligand-independent activation of steroid hormone receptors. Science 254:1636-1639
20. Ignar-Trowbridge DM, Nelson KG, Bidwell MC, Curtis SW, Washburn TF, Machlachlan JA, Korach KS (1992) Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci USA 89: 4658-4662
21. Ignar-Trowbridge DM, Teng CT, Ross KA, Parker MG, Korach KS, McLachlan JA (1993) Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol Endocrinol 7:992-998
22. Schrader WT, O'Malley BW (1972) Progesterone-binding components of chick oviduct. IV. Characterization of purified subunits. J Biol Chem 247:51-59
23. Horwitz KB, Alexander PS (1983) In situ photolinked nuclear progesterone receptors of human breast cancer cells: subunit molecular weights after transformation and translocation. Endocrinol 113:2195-2201
24. Loosfelt H, Logeat F, Hai MTV, Milgrom E (1984) The rabbit progesterone receptor. Evidence for a single steroid-binding subunit and characterization of receptor mRNA. J Biol Chem 259:14196-14202
25. Kastner P, Krust A, Turcotte B, Strupp U, Tora L, Gronemeyer H, Chambon P (1990) Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J 9:1603-1614
26. Conneely OM, Kettelberger DM, Tsai M-J, Schrader WT, O'Malley BW (1989) The chicken progesterone receptor A and B isoforms are products of an alternate translation initiation event. J Biol Chem 264:14062-14064
27. Tora L, Gronemeyer H, Turcotte B, Gaub M, Chambon P (1988) The N-terminal region of the chicken progesterone receptor specifies target gene activation. Nature 333:185-188
28. McDonnell DP, Goldman ME (1994) RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism. J Biol Chem 269:11945-11949
29. Meyer ME, Pornon A, Ji JW, Bocquel MT, Chambon P, Gronemeyer H (1990) Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor. EMBO J 9:3923-3932
30. Wen DX, Xu Y-F, Mais DE, Goldman ME, McDonnell DP (1994) The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Mol Cell Biol 14:8356-8364
31. Zhang Y, Bai W, Allgood VE, Weigel NL (1994) Multiple signaling pathways activate the chicken progesterone receptor. Mol Endocrinol 8:577-584
32. Turgeon JL, Waring DW (1994) Activation of the progesterone receptor by the gonadotropin-releasing hormone self-priming signaling pathway. Mol Endocrinol 8:860-869
33. Mani SK, Allen JM, Clark JH, Blaustein JD, O'Malley BW (1994) Convergent pathways for steroid hormone- and neurotransmitter-induced rat sexual behavior. Science 265:1246-1249
34. Mani SK, Blaustein JD, Allen JM, Law SW, O'Malley BW, Clark JH (1994) Inhibition of rat sexual behavior by antisense oligonucleotides to the progesterone receptor. Endocrinol 135:1409-1414
35. Beck CA, Weigel NL, Edwards DP (1992) Effects of hormone and cellular modulators of protein phosphorylation on transcriptional activity, DNA binding, and phosphorylation of human progesterone receptors. Mol Endocrinol 6:607-620
36. Beck CA, Weigel NL, Moyer ML, Nordeen SK, Edwards DP (1993) The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways. Proc Natl Acad Sci USA 90:4441-4445
37. Sartorius CA, Tung L, Takimoto GS, Horwitz KB (1993) Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP. J Biol Chem 268:9262-9266
38. Sartorius CA, Groshong SD, Miller LA, Powell RL, Tung L, Takimoto GS, Horwitz KB (1994) New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP. Cancer Res 54:3868-3877
39. Kazmi SMI, Visconti V, Plante RK, Ishaque A, Lau C (1993) Differential regulation of human progesterone receptor A and B form-mediated traits-activation by phosphorylation. Endocrinol 144:1230-1238
40. Philpott AJ, Shahid M (1996) Dopamine-mediated activation of the human progesterone receptor. Cell Mol Neurobiol 16:417-420
41. Bai W, Rowan BG, Allgood VE, O'Malley BW, Weigel NL (1997) Differential phosphorylation of chicken progesterone receptor in hormone-dependent and ligand-independent activation. J Biol Chem 272:10457-10463
42. Denner LA, Schrader WT, O'Malley BW, Weigel NL (1990) Hormonal regulation and identification of chicken progesterone receptor phosphorylation sites. J Biol Chem 265:16548-16555
43. Poletti A, Weigel NL (1993) Identification of a hormone-dependent phosphorylation site adjacent to the DNA-binding domain of the chicken progesterone receptor. Mol Endocrinol 7:241-246
44. Chakravarti D, LaMorte VJ, Nelson MC, Nakajima T, Schulman IG, Juguilon H, Montminy M, Evans RM (1996) Role of CBP/P300 in nuclear receptor signalling. Nature 383:99-103
45. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin S-C, Heyman RA, Rose DW, Glass CK, Rosenfeld MG (1996) A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414
46. Smith CL, Onate SA, Tsai M-J, O'Malley BW (1996) CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proc Natl Acad Sci USA (in press)
47. Cavailles V, Dauvois S, L'Horset F, Lopez G, Hoare S, Kushner PJ, Parker MG (1995) Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J 14:3741-3751
48. vom Baur E, Zechel C, Heery D, Heine MJS, Garnier JM, Vivat V, Le Douarin B, Gronemeyer H, Chambon P, Losson R (1996) Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J 15:110-124
49. Smith CL, Conneely OM, O'Malley BW (1993) Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone. Proc Natl Acad Sci USA 90:6120-6124
50. Newton CJ, Buric R, Trapp T, Brockmeier S, Pagotto U, Stalla GK (1994) The unliganded estrogen receptor (ER) transduces growth factor signals. J Steroid Biochem Molec Biol 48:481-486
51. Ignar-Trowbridge DM, Pimentel M, Parker MG, McLachlan JA, Korach KS (1996) Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology 137:1735-1744
52. Ignar-Trowbridge DM, Pimentel M, Teng CT, Korach KS, McLachlan JA (1995) Cross talk between peptide growth factor and estrogen receptor signaling systems. Environ Health Presp 103:35-38
53. Pietras RJ, Arboleda J, Reese DM, Wongvipat N, Pegram MD, Ramos L, Gorman CM, Parker MG, Sliwkowski MX, Slamon DJ (1995) HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene 10:2435-2446
54. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P (1995) Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491-1494
55. Migliaccio A, DiDomenico M, Green S, deFalco A, Kajtaniak EL, Blasi F, Chambon P, Auricchio F (1989) Phosphorylation on tyrosine of in vitro synthesized human estrogen receptor activates its hormone binding. Mol Endocrinol 3:1061-1069
56. Arnold SF, Notides AC (1995) An antiestrogen: A phosphotyrosyl peptide that blocks dimerization of the human estrogen receptor. Proc Natl Acad Sci USA 92:7475-7479
57. Weis KE, Ekena K, Thomas JA, Lazennec G, Katzenellenbogen BS (1996) Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein. Mol Endo 10:1388-1398
58. Aronica SM, Katzenellenbogen BS (1991) Progesterone receptor regulation in uterine cells: stimulation by estrogen, cyclic adenosine 3′,5′-monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors. Endocrinol 128:2045-2052
59. Curtis SW, Washburn T, Sewall C, DiAugustine R, Lindzey J, Couse JF, Korach KS (1996) Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor. Proc Natl Acad Sci USA 93:12626-12630
60. Fujimoto N, Katzenellenbogen BS (1994) Alteration in the agonist/antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: antiestrogen selectively and promoter dependence. Mol Endocrinol 8:296-304
61. Ince BA, Montano MM, Katzenellenbogen BS (1994) Activation of transcriptionally inactive human estrogen receptors by cyclic adenosine 3′,5′-monophosphate and ligands including antiestrogens. Mol Endocrinol 8:1397-1406
62. Aronica SM, Katzenellenbogen BS (1993) Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-1. Mol Endocrinol 7:743-752
63. LeGoff P, Montano MM, Schodin DJ, Katzenellenbogen BS (1994) Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. J Biol Chem 269:4458-4466
64. Bunone G, Briand P-A, Miksicek RJ, Picard D (1996) Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 15:2174-2183
65. Arnold SF, Obourn JD, Yudt MR, Carter TH, Notides AC (1995) In vivo and in vitro phosphorylation of the human estrogen receptor. J Steroid Biochem Molec Biol 52:159-171
66. Patrone C, Ma ZQ, Pollio G, Agrati P, Parker MG, Maggi A (1996) Cross-coupling between insulin and estrogen receptor in human neuroblastoma cells. Mol Endo 10:499-507
67. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H (1994) Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res 54:5474-5478
68. Culig Z, Hobisch A, Hittmair A, Cronauer MV, Radmayr C, Zhang J, Bartsch G, Klocker H (1996) Synergistic activation of androgen receptor by androgen and luteinizing hormone releasing hormone in prostatic carcinoma cells. Prostate (in press)
69. Nazareth LV, Weigel NL (1996) Activation of the human androgen receptor through a protein kinase A signalling pathway. J Biol Chem 271:19900-19907
70. Rennie PS, Bruchovsky N, Leco KJ, Sheppard PC, McQueen SA, Cheng H, Snoek R, Hamel A, Bock ME, MacDonald BS, Nickel BE, Chang CS, Liao SS, Cattini PA, Matusik RJ (1993) Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene. Mol Endocrinol 7:23-36
71. Ikonen T, Palvimo JJ, Kallio PJ, Reinikainen P, Janne OA (1994) Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation. Endocrinol 4:1359-1366
72. Reinikainen P, Palvimo JJ, Janne OA (1996) Effects of mitogens on androgen receptor-mediated transactivation. Endocrinology 137:4351-4357
73. de Ruiter PE, Teuwen R, Trapman J, Dijkema R, Brinkmann AO (1995) Synergism between androgens and protein kinase C on androgen-regulated gene expression. Mol Cell Endocrinol 110: R1-R6
74. Jenster G, deRuiter PE, van der Korput AGM, Kuiper GGJM, Trapman J, Brinkmann AO (1994) Changes in the abundance of androgen receptor isotypes: Effects of ligand treatment, glutamine-stretch variation, and mutation of putative phosphorylation sites. Biochem 33:14064-14072
75. Rangarajan PN, Umesono K, Evans RM (1992) Modulation of glucocorticoid receptor function by protein kinase A. Mol Endocrinol 6:1451-1457
76. Nordeen SK, Moyer ML, Bona BJ (1994) The coupling of multiple signal transduction pathways with steroid response mechanisms. Endocrinol 134:1723-1732
77. Moyer ML, Borror KC, Bona BJ, DeFranco DB, Nordeen SK (1993) Modulation of cell signaling pathways can enhance or impair glucocorticoid-induced gene expression without altering the state of receptor phosphorylation. J Biol Chem 268:22933-22940
78. Nordeen SK, Bona BJ, Moyer ML (1993) Latent agonist activity of the steroid antagonist, RU486, is unmasked in cells treated with activators of protein kinase A. Mol Endocrinol 7:731-742
79. Huggenvik JI, Collard MW, Kim Y-W, Sharma RP (1993) Modification of the retinotic acid signaling pathway by the catalytic subunit of protein kinase A. Mol Endocrinol 7:543-550
80. Matkovits T, Christakos S (1995) Ligand occupancy is not required for vitamin D receptor and retinoid receptor-mediated transcriptional activation. Mol Endocrinol 9:232-242
81. Fahrner TJ, Carroll SL, Milbrandt J (1990) The NGFI-B protein, an inducible member of the thyroid/steroid receptor family, is rapidly modified posttranslationally. Mol Cell Biol 10:6454-6459
82. Hazel TG, Misra R, Davis IJ, Greenberg ME, Lau LF (1991) Nur77 is differentially modified in PC12 cells upon membrane depolarization and growth factor treatment. Mol Cell Biol 11:3239-3246
83. Zhang Y, Beck CA, Poletti A, Edwards DP, Weigel NL (1995) Identification of a group of Ser-Pro motif hormone-inducible phosphorylation sites in the human progesterone receptor. Mol Endocrinol 9:1029-1040
84. Bai W, Tullos S, Weigel NL (1994) Phosphorylation of Ser 530 facilitates hormone-dependent transcriptional activation of the chicken progesteron receptor. Mol Endocrinol 8:1465-1473
85. Bai W, Weigel NL (1996) Phosphorylation of Ser 211 in the chicken progesterone receptor modulates its transcriptional activity. J Biol Chem 271:12801-12806